Methanolic root extract of Rauwolfia serpentina lowers atherogenic dyslipidemia, arteriosclerosis and glycosylation indices in type 1 diabetic mice

Journal of Applied Pharmaceutical Science

Volumn 5, Issue 8, 2015, Pages 61-67

  Azmi, Muhammad Bilal ^a,b   Qureshi, Shamim A ^a   Rais, Sumera ^c   Sultana, Saleha ^a  

^a UNIVERSITY OF KARACHI   (Pakistan)

^b DOW UNIVERSITY OF HEALTH SCIENCES   (Pakistan)

^c FEDERAL URDU UNIVERSITY OF ARTS   (Pakistan)

Author keywords

Atherogenic index; Cholesterol; Rauwolfia serpentina; Triglycerides

Indexed keywords

EID: 84940848156     PISSN: None     EISSN: 22313354     Source Type: Journal    
DOI: 10.7324/JAPS.2015.50810     Document Type: Article

References (29)

1. Adaramoye O, Amanlou M, Habibi-Rezaei M, Pasalar P, Ali MM . Methanolic extract of African mistletoe (Viscum album) improves carbohydrate metabolism and hyperlipidemia in streptozotocin-induced diabetic rats. Asian Pac J Trop Med, 2011; 5:427-433.
2. Adeneye AA, Olagunju JA. Preliminary hypoglycemic and hypolipidemic activities of the aqueous seed extract of Carica papaya Linn. in Wistar rats. Biol Med, 2009; 1:1-10.
3. Azmi MB, Qureshi SA. Methanolic root extract of Rauwolfia serpentina Benth improves the glucose tolerance in Wister mice. J Food Drug Anal, 2012a; 20:54-58.
4. Azmi MB, Qureshi SA. Rauwolfia serpentina ameliorates hyperglycemic, haematinic and antioxidant status in alloxan-induced diabetic mice. J App Pharm Sci, 2013; 3:136-141.
5. Azmi MB, Qureshi SA. Methanolic root extract of Rauwolfia serpentina Benth improves the glycemic, antiatherogenic, and cardioprotective indices in alloxan-induced diabetic mice. Adv Pharmacol Sci, 2012b; article ID 376429. 11pages.
6. Clark NG, Fox KM, Grandy S. Symptoms of diabetes and their association with the risk and presence of diabetes. Diabetes Care, 2007; 30:2868-2873.
7. Dey A, De JN. Ethnobotanical aspects of Rauwolfia serpentina (L). Benth. ex Kurz. in India, Nepal and Bangladesh. J Med Plant Res, 2011; 5:144-150.
8. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem, 1972 ; 18:499-502.
9. Ganugapati J, Baldwa A, Lalani S. Docking studies of Rauwolfia serpentina alkaloids as insulin receptor activators. Int J Computer Applicat, 2012; 43:32-37.
10. Hermans MP, Fruchart JC. Reducing residual vascular risk in patients with atherogenic dyslipidaemia: where do we go from here? Clin Lipidology, 2010; 5:811-826.
11. Hermans M P, Ahn SA, Rousseau MF. The atherogenic dyslipidemia ratio [log(TG)/HDL-C] is associated with residual vascular risk, beta-cell function loss and microangiopathy in type 2 diabetes females. Lipids Health Dis, 2012; 11:132
12. Kumar A, Singh V. Atherogenic dyslipidemia and diabetes mellitus: what's new in the management arena?. Vasc Health Risk Manag, 2010; 6:665-669.
13. Kwon SW, Yoon SJ, Kang TS, Kwon HM, Kim JH, Rhee J, et al. Significance of small dense low density lipoprotein as a risk factor for coronary artery disease and acute coronary syndrome. Yonsei Med J 2006; 47:405-14.
14. Lorenzi M. The polyol pathway as a mechanism for diabetic retinopathy: attractive, elusive, and resilient. Exp Diabetes Res, 2007, Article ID 61038: 10 pages.
15. Mahato RV, Gyawali P, Raut PP, Regmi P, Singh KP, Pandeya DR, Gyawali P. Association between glycaemic control and serum lipid profile in type 2 diabetic patients: Glycated haemoglobin as a dual biomarker. Biomed Res, 2011; 22:375-380.
16. Manjunath CN, Rawal JR, Irani PM, Madhu K. Atherogenic dyslipidemia. Indian J Endocr Metab. 2013; 17:969-76.
17. Michael B, Yano B, Sellers RS, Perry R, Morton D, Roome N, Johnson JK, Schafer K. Evaluation of organ weights for rodent and non-rodent toxicity studies: A review of Regulatory Guidelines and a Survey of Current Practices. Toxicologic Pathology. 2007; 35:742-750.
18. Pathania S, Randhawa V, Bagler G. Prospecting for novel plant-derived molecules of rauvolfia serpentina as inhibitors of aldose reductase, a potent drug target for diabetes and its complications. PLoS ONE, 2013; 8:e61327.
19. Peters J M, Boyd EM. Organ weights and water levels of the rat following reduced food intake. J Nutr, 1966; 90:354-60.
20. Pfeiffer CJ. A mathematical evaluation of the thymic weight parameter. Toxicol Appl Pharmacol. 1968; 13:220-7.
21. Pitchai D, Manikkam R, Rajendran SR, Pitchai G. Database on pharmacophore analysis of active principles, from medicinal plants. Bioinformation. 2010 ; 5:43-45.
22. Qureshi SA, Nawaz A, Udani SK, Azmi B. Hypoglycaemic and hypolipidemic activities of Rauwolfia serpentina in alloxan - induced diabetic rats. Int J Pharmacol. 2009; 5:323-326.
23. Qureshi SA, Udani SK. Hypolipidaemic activity of Rauwolfia serpentina Benth. Pak J Nutr 2009; 8:1103-1106.
24. Qureshi SA, Kamran M, Asad M, Zia A, Lateef T, Azmi MB. A preliminary study of Santalum album on serum lipids and enzymes. Global J Pharmacol. 2010; 4:71-74.
25. Rabbani N, Godfrey L, Xue M, Shaheen F, Geoffrion M, Milne R, Thornalley PJ. Glycation of LDL by Methylglyoxal Increases Arterial Atherogenicity A Possible Contributor to Increased Risk of Cardiovascular Disease in Diabetes. Diabetes, 2011; 60:1973-1980.
26. Thuong PT, Pokharel YR, Lee MY, Kim SK, Bae K, Su ND, Oh WK, Kang KW. Dual Anti-oxidative Effects of Fraxetin Isolated from Fraxinus Rhinchophylla. Biol Pharm Bull 2009; 32:1527-1532.
27. Tiwari S. Plant: A rich source of herbal medicine. J Nat Prod. 2008; 1:27-35.
28. Virani SS. Non-HDL Cholesterol as a Metric of Good Quality of Care Opportunities and Challenges. Tex Heart Inst J, 2011; 38:160-162.
29. Zargar BA, Masoodi MH, Ahmed B, Ganie SA. Antihyperlipidemic and Antioxidant Potential of Paeonia emodi Royle against High-Fat Diet Induced Oxidative Stress. ISRN Pharmacol, Volume 2014, Article ID 182362, 7 pages.